Oct 13, 2026 06:45AM
Oct 13, 2026 06:45AM
Oct 7, 2026 09:59AM
Sep 25, 2026 04:30PM
Sep 25, 2026 04:30PM
Sep 25, 2026 06:45AM
Sep 25, 2026 06:45AM U.S. FDA Approves WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma With a Clear Cell Component (ccRCC)
Sep 22, 2026 06:45AM
Sep 22, 2026 06:45AM
Sep 21, 2026 06:45AM
Sep 21, 2026 06:45AM
Sep 18, 2026 06:55AM
Sep 18, 2026 06:55AM
Sep 10, 2026 08:30AM Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
Sep 8, 2026 04:21PM
Aug 19, 2026 06:45AM
Aug 19, 2026 06:45AM
Aug 6, 2026 06:45AM
Aug 6, 2026 06:45AM
Aug 4, 2026 06:30AM
Jul 21, 2026 10:00AM Gilead to present lenacapavir HIV trial data at AIDS 2026
Jul 21, 2026 10:00AM
Jul 21, 2026 10:00AM
Jul 21, 2026 10:00AM
Jul 17, 2026 07:07AM
Jul 16, 2026 06:45AM
Jul 16, 2026 06:45AM
Jul 15, 2026 07:00AM Merck to present HIV pipeline data at AIDS 2026 conference
Jul 15, 2026 07:00AM
Jul 15, 2026 06:45AM
Jul 15, 2026 06:45AM
Jul 10, 2026 02:10PM
Jul 10, 2026 02:10PM
Jul 8, 2026 08:00AM
Jul 8, 2026 08:00AM EMD Serono Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations
Jun 29, 2026 06:45AM
Jun 29, 2026 06:45AM
Jun 25, 2026 06:45AM
Jun 25, 2026 06:45AM
Jun 24, 2026 08:30AM
Jun 24, 2026 08:30AM
Jun 24, 2026 06:45AM EU approves Merck's Keytruda plus Padcev for bladder cancer
Jun 24, 2026 06:45AM
Jun 18, 2026 06:45AM
Jun 18, 2026 06:45AM
Jun 12, 2026 04:10PM
Jun 12, 2026 04:10PM
Jun 8, 2026 04:35PM
Jun 8, 2026 04:35PM Gilead and Merck Announce Positive Topline Results From Two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment
Jun 8, 2026 04:30PM

334,574 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All